Both the Tsc2−/− MEFs and 621-102 AML cells recovered after treatment with APX3330, APX2009, or APX2014 (similar to the DMSO control), as observed by cells migrating out of the adhered spheroid within a 48 h period (Supplementary Figure S3). The gene discussed is TSC2; the disease is acute myeloid leukemia.